ОТНОСТНО ТОЗИ ЕПИЗОД
In this episode, join Dr. Carrie Bedient from Fertility Center of Las Vegas and Dr. Susan Hudson from Texas Fertility Center as they explore the evolving role of Preimplantation Genetic Testing for Aneuploidy (PGT-A) in improving IVF outcomes and helping patients make more informed decisions on their fertility journey. The docs discuss how PGT-A is used to identify embryos with the highest potential for implantation, the science behind embryo genetic testing, and the complexities of interpreting mosaic embryo results. The conversation also examines the fascinating and often debated field of reproductive immunology, highlighting what current research tells us about the immune system's role in fertility and where evidence is still emerging. They break down the risks and benefits of PGT-A across different age groups, why it may be particularly valuable for women over 35 or those with recurrent pregnancy loss, and the ethical considerations surrounding embryo selection and transfer.
